Intraperitoneal chemotherapy. Review

Автор: Saevets V.V., Vazhenin A.V., Privalov A.V., Chernova L.F., Simakova O.A., Kurchenkova O.V., Taratonov A.V., Mukhin A.A., Arzhannikova D.F.

Журнал: Вестник Челябинского государственного университета. Образование и здравоохранение @vestnik-csu-obrazovaniye-i-zdravookhraneniye

Статья в выпуске: 1 (4), 2018 года.

Бесплатный доступ

The incidence of malignant neoplasms in Russia has a steady upward trend. Among the causes of death, malignant neoplasms take the second place, and their share only grows every year. More than a quarter of all newly diagnosed malignant neoplasms are localized in the abdominal cavity and small pelvis. The course of these malignant neoplasms can often include peritoneal carcinomatosis. The development of this condition is associated with an unfavorable course of the disease. The combination of surgical treatment in the amount of full / optimal cytoreduction and systemic chemotherapy is standard, but cannot provide high rates of survival. This article focuses on a promising treatment method - intraperitoneal chemotherapy in its various variations. When carrying out this technique, drugs are injected directly into the abdominal cavity.

Еще

Intraperitoneal chemotherapy, hipac, pipac, peritoneal carcinomatosis

Короткий адрес: https://sciup.org/170191230

IDR: 170191230

Статья обзорная